By the end of 2022, the global market for drugs used in farm animals is estimated to reach a value of US$ 17.2 billion. The market is projected to grow at a CAGR of 5.5% from 2022 to 2032 and is expected to be worth US$ 29.4 billion by the end of 2032. Livestock animals dominate the market, representing around 92.4% of the market in 2021.
Healthy and productive animals are crucial for the food and economic stability of omnivores, particularly in low- and middle-income countries where many people rely on animal husbandry. The Health for Animals Organization reports that 1.3 billion people worldwide raise livestock, highlighting the importance of regulating and preventing animal diseases to achieve the Sustainable Development Goals and provide a global public benefit.
To remain ahead of your competitors, request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2402
Antibiotics are commonly used to treat sick animals, but failure to adhere to drug withdrawal periods can result in contaminated products, raising concerns about their safety when consumed by humans. Products that contain an excess amount of antibiotic residue are considered unfit for consumption and should be disposed of in a way that minimizes the risk of environmental contamination.
Antimicrobial-resistant bacteria can be transmitted to humans directly or indirectly through contaminated environments, contaminated food, or direct contact with animals. As a result, pharmaceutical companies are expected to develop innovative medications for farm animals to address these concerns.
US Farm Animal Drugs Market
The United States dominates the North American area, with a farm animal Drugs market share of approximately 56.5% in 2021. According to FMI, the country is anticipated to maintain its current growth rate during the forecast year. Rising prevalence of numerous animal diseases caused by increased globalisation, strong demand for meat exports from the United States, and antibiotic resistance in animals are expected to drive important stakeholders in the country to produce breakthrough farm animal medications.
Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you@ https://www.futuremarketinsights.com/ask-question/rep-gb-2402
Germany Farm Animal Drugs Market
In 2021, Germany owned a 2.7% share of the worldwide farm animal medicines market. Stringent legislation restricting the use of antibiotics to increase farm animal productivity is one factor affecting antibiotic sales in the country. The majority of cattle production in Germany is highly industrialised and modernised, with increasing percentages of output employing various biosecurity measures and disease-threat reduction strategies. Regulations or consumer pressures have encouraged the country to adopt disease-reduction initiatives, which would boost the German farm animal medicine industry.
Competitive Landscape
Key companies profiled in the report are Bayer AG, Boehringer Ingelheim GmbH, Zoetis, Inc., Ceva Santé Animale, Dechra Drugs PLC, Elanco Animal Health (Sub. Eli Lilly), Merck Animal Health, Virbac SA, Vetoquinol SA, Intas Animal Health, Alembic Animal Health, Sequent Scientific, Hester Biosciences, Ashish Life Sciences, Ouro Fino Saude Animal (Ourofino), Zydus Animal Health (Sub. Cadila Healthcare Ltd), Phibro Animal Health Corporation, Nippon Zenyaku Kogyo Co., Ltd, Norbrook, Kyoritsu Seiyaku Corporation.
More Insights Available
North America holds a significant share of the global animal drugs market due to the high prevalence of various animal diseases and increasing awareness about animal health among pet owners. Additionally, the presence of major animal health companies in the region is driving the growth of the market.
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/2402
Product Type
- Anti-Infective
- Parasiticides
- Endo-parasiticides
- Ecto-parasiticides
- Endectocides
- Anti-inflammatory
- Anesthetics
- Analgesics
- Hormones and related products
- Others
Animal Type
- Livestock Animals
- Ruminants
- Swine
- Poultry
- Equine
Route of Administration
- Oral
- Parenteral
- Topical
- Others
Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- Others
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
